Neurotech Pharmaceuticals, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCumberland, RI
SAM.gov UEISSYBDBA61GV4
Neurotech Pharmaceuticals, Inc. is a private clinical stage biotech company developing encapsulated cell therapy for chronic eye diseases, specifically macular telangiectasia type 2, a retinal disease. The company's Encapsulated Cell Therapy platform releases Ciliary Neurotrophic Factor, a protein designed to protect against photoreceptor loss in the retina. The company serves the ophthalmology and retinal disease treatment industries.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Neurotech Pharmaceuticals, INC | Cumberland | RI | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.